CI

At a glance

ClinicalIndex Comparison Record
Phase 1Recruiting· 80 target
Drug / intervention
Washed Microbiota Transplantationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06030752
NCT06030752Phase 1RecruitingHigh MomentumUpdated 9mo ago

Washed Microbiota Transplantation (WMT) for Autism Spectrum Disorder (ASD)

The Second Hospital of Nanjing Medical University·interventional·Posted Sep 11, 2023·Updated Sep 5, 2025

In Brief

A Phase 1 clinical trial evaluating Washed Microbiota Transplantation for Autism Spectrum Disorder. Currently recruiting, targeting 80 participants across 2 sites.

Signals

Enrolling ahead of pace

Detailed Summary

Autism Spectrum Disorder (ASD) is a group of serious neurodevelopmental disorders. A significant comorbidity exists between ADHD and ASD: 30%-50% of individuals with ASD exhibit ADHD symptoms, and two-thirds with ADHD show ASD traits. Intestinal microbial disturbance is common in children with ASD. A great deal of evidence shows that intestinal microbes can influence the brain to play its role through "gut-brain-microbiota axis". We intend to explore the role of Washed Microbiota Transplantation in improving symptoms of children in ASD with or without ADHD; To study the potential etiological mechanism of WMT for the neurodevelopmental disorders.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

Phase 1Recruiting
2024202520262027
First PostedSep 11, 2023
Enrollment StartSep 20, 2023
Primary CompletionApr 4, 2027
Study CompletionMay 1, 2027
TodayJul 1, 2026
Enrollment to primary: 3.5 yearsPosted 2.8 years agoPrimary completion in 9 months

Interventions

Washed Microbiota Transplantationdrug

The prepared microbiota suspension was infused into the participates' lower gut.